As of August 2025, President Donald Trump has publicly indicated that his administration is “looking at” reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act. While this move stops short of federal legalization, it could fundamentally reshape the business landscape for cannabis operators—especially around IRC Section 280E, banking access, and capital markets.
280E: A Longstanding Burden on Operators
Under Section 280E, businesses trafficking in Schedule I or II substances cannot deduct ordinary and necessary business expenses. This means cannabis companies are taxed on their gross revenue minus their cost of goods sold (COGS), not on their true net income.
The Financial Impact of Losing 280E
If rescheduling proceeds, cannabis operators would no longer be bound by 280E. The shift would be dramatic:
- Today (with 280E): Effective tax rates can soar above 50%–70%, especially for retail operators with high rent, staffing, and compliance costs.
- Post-Rescheduling (without 280E): Companies could deduct standard business expenses, reducing effective tax rates closer to the 21% corporate rate.
Example: A dispensary with $10M in revenue, $4M in COGS, and $3M in operating expenses might currently pay tax on $6M in income ($10M revenues less $4M in COGs). After rescheduling, it would be taxed only on $3M true net income ($10M revenue less $4M in COGs less $3M in operating expenses)—potentially saving around $630,000 in taxes annually.
The result: higher profitability, stronger cash flow, and increased company valuations.
Access to Banking and Capital
Today, cannabis businesses struggle to access traditional banking because of federal restrictions, leaving many reliant on cash transactions or high-cost private lenders. Rescheduling would not legalize cannabis outright, but it could ease compliance fears for banks and credit unions.
This shift could:
- Encourage more financial institutions to provide deposit, lending, and payment services
- Lower capital costs by attracting institutional investors
- Improve transparency and reduce security risks from cash-heavy operations
Strategic Advantages for Operators
Rescheduling to Schedule III could trigger ripple effects across the industry:
- Tax Relief: Removal of 280E frees significant capital for reinvestment.
- Enhanced Valuations: Investors value businesses on after-tax earnings, boosting multiples.
- M&A Acceleration: Larger operators may pursue acquisitions of smaller, newly profitable peers.
- Operational Stability: Access to banking reduces risks and creates stronger financial systems.
Remaining Challenges
Even with rescheduling, cannabis would remain federally illegal, and regulatory inconsistencies across states would persist. Issues such as interstate commerce, licensing, and compliance costs will continue to complicate operations. For now, rescheduling represents a critical but partial step toward broader reform.
Conclusion
The potential reclassification of cannabis to Schedule III could be a turning point for operators, offering relief from 280E and opening doors to banking and capital access. For businesses prepared with clean financials, robust compliance, and defensible structures, this shift could transform cash-strapped operations into scalable, profitable enterprises.
At Aura Advisors, we partner with cannabis operators to anticipate these changes—building strategies that balance today’s realities with tomorrow’s opportunities.
For more reading:
Aura Advisors is a boutique tax consulting and compliance firm working with start-ups, emerging growth companies, and affluent individuals. Making it safer for good people and good companies to continue to do good things.